feed,title,long_url,short_url
SeekingAlpha,Anavex Stock: A Risky Bet On CNS Drug Development (Rating Downgrade),https://seekingalpha.com/article/4725534,
SeekingAlpha,Blackstone: Fundamental Resilience Met With Questionable Valuation,https://seekingalpha.com/article/4725533,
SeekingAlpha,DocuSign: A Midcap Worth Considering,https://seekingalpha.com/article/4725532,
